Anterix (ATEX) Profitability On Low Revenue Fuels Debate Over Earnings Quality
Anterix Inc. ATEX | 0.00 |
Anterix (ATEX) closed out FY 2026 with fourth quarter revenue of US$1.96 million and basic EPS of US$0.99, alongside net income of US$18.52 million, putting fresh numbers behind its recent move into profitability. Over the last six reported quarters, revenue has ranged between about US$1.39 million and US$1.96 million, while quarterly basic EPS has swung from a loss of US$0.35 to a high of US$2.86, giving investors a clear view of how earnings have tracked alongside relatively stable top line figures. With trailing 12 month EPS of US$4.85 and net income of US$90.64 million, the latest report sharpens the focus on how much of that profitability is translating into durable margins rather than one off gains.
See our full analysis for Anterix.With the headline numbers on the table, the next step is to compare these results with the most common narratives around Anterix to see which views hold up and which may need a rethink.
Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.
TTM profit of US$90.6 million on just US$6.5 million revenue
- Over the last twelve months, Anterix reported total revenue of US$6.5 million and net income of US$90.6 million, which means reported profit is far larger than the top line.
- What stands out against the bullish narrative is that a large part of this profitability comes from non cash items, so while bulls focus on long duration spectrum monetization and potential free cash flow, the current 61.6% average five year earnings growth and strong TTM net income are heavily influenced by accounting gains rather than recurring cash earnings.
- Bulls point to grid modernization and 900 megahertz spectrum value as support for future cash flows, but the risk summary flags non cash earnings as a major issue for earnings quality.
- Investors weighing the optimistic view need to separate the US$90.6 million of TTM net income from the relatively modest US$6.5 million revenue base when thinking about how repeatable these results are.
Bulls argue that these reported profits are just the start of a much longer spectrum monetization story, so if you want to see how that case is built out in detail, check out the 🐂 Anterix Bull Case
Quarterly swings from losses to high EPS
- Within FY 2026, basic EPS moved from a loss of US$0.35 in Q3 to US$0.99 in Q4, with a spike to US$2.86 in Q2, while net income ranged from a loss of US$6.6 million in Q3 to US$53.5 million in Q2 on quarterly revenue that stayed between US$1.4 million and US$2.0 million.
- Critics in the bearish narrative highlight that roughly 85% of spectrum is still to be monetized and that earnings today are supported by one time license related gains, and this pattern of sharp EPS and net income swings against relatively steady revenue aligns with that concern that current profitability may rely on timing of transactions rather than a broad, recurring revenue base.
- Bears argue that as remaining licenses are cleared and complex systems addressed, these large, irregular gains could ease, which would likely bring EPS closer to what the small revenue base can support.
- The Q3 FY 2026 loss alongside revenue of US$1.6 million, sandwiched between highly profitable quarters with similar revenue levels, illustrates how sensitive results are to individual monetization events that the bearish view treats as hard to repeat on a smooth schedule.
Skeptics point to these uneven results as a warning sign, so if you want to see the full cautious case laid out, including spectrum and licensing risks, take a look at the 🐻 Anterix Bear Case
17x P/E against DCF value of US$57.84
- The stock trades at a trailing P/E of 17x, slightly below the US market P/E of 18.6x and below the 36.5x peer average, while a DCF fair value of US$57.84 sits below the current share price of US$81.44.
- The balanced narrative talks about long term grid investment and a large unmonetized spectrum pool, yet the combination of a 17x trailing P/E, a DCF fair value that is below the market price, and analyst expectations that earnings could be around US$0.9 million with EPS of US$0.05 in a few years highlights a tension between today’s valuation and the much smaller earnings figures that analysts are using in their price target framework.
- Consensus price targets are built on scenarios where profit margins move toward around 13.5% and earnings fall sharply from the current TTM figure, even though the share price today is well above the DCF fair value cited.
- For readers, that means checking whether the 17x P/E on US$4.85 of TTM EPS feels supported once non cash earnings are adjusted for, given that the DCF value of US$57.84 is below the US$81.44 market price while still assuming ongoing spectrum monetization.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Anterix on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Mixed signals in the story so far? If you want to move quickly from headlines to your own judgment, start by weighing the 2 key rewards and 1 important warning sign.
See What Else Is Out There
The company leans heavily on non cash gains and irregular spectrum transactions, with modest revenue and volatile EPS making current profitability look hard to repeat.
If that mix of accounting driven earnings and sharp swings in results makes you uneasy, it could be worth shifting attention toward 67 resilient stocks with low risk scores that focus on steadier financial profiles and lower overall risk.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
